Retatrutide is an experimental multi-agonist peptide being studied for its potential to support metabolic health. It works by targeting several hormone pathways involved in appetite regulation, energy balance, and glucose control. Early research shows that it may help improve weight management and metabolic markers, but it is still in clinical trials and not approved for general use. Scientists continue to study its safety, effectiveness, and long-term impact before it can become an official treatment option…
